Unraveling the Prevalence of Antibiotic Resistance in Stenotrophomonas maltophilia: Insights into an Emerging Nosocomial Pathogen

Henry J. Parra-Vera; Dayci C. Buele-Chica; Galo G. Farfán-Cano; Andrea M. Zúñiga-Vinueza

doi:10.54034/mic.e1893

Authors

Henry J. Parra-Vera Microbiological Research Centre (CIM), Guayaquil, Ecuador; University of Guayaquil, Guayaquil, Ecuador
Dayci C. Buele-Chica Microbiological Research Centre (CIM), Guayaquil, Ecuador; University of Guayaquil, Guayaquil, Ecuador
Galo G. Farfán-Cano University of Guayaquil, Guayaquil, Ecuador; Rey Juan Carlos University, Mostoles, Spain; Society of Infectious diseases of Guayas, Guayaqui,l, Ecuador; Northern Guayaquil General Hospital "Los Ceibos", Guayaquil, Ecuador https://orcid.org/0000-0001-8447-5764
Andrea M. Zúñiga-Vinueza Catholic University of Santiago de Guayaquil, Ecuador https://orcid.org/0009-0000-2962-6945

DOI:

https://doi.org/10.54034/mic.e1893

Keywords:

Stenotrophomonas, Stenotrophomonas maltophilia, epidemiology, pathogenesis, diagnosis, treatment, antimicrobial resistance

Abstract

Introduction: stenotrophomonas maltophilia is a clinically relevant opportunistic and nosocomial pathogen with increasing concerns regarding antibiotic resistance. Accurate diagnosis and identification are crucial for effective treatment, and misidentification can occur, thereby emphasizing the need for appropriate laboratory testing and surveillance. This review aimed to evaluate the epidemiology, pathogenesis, diagnosis, treatment, and antimicrobial resistance of Stenotrophomonas spp. Materials and Methods. A systematic literature review was conducted using the PubMed Central Database. Inclusion criteria included studies published in open-access scientific journals within the last five years, reporting information on Stenotrophomonas spp. epidemiology, pathogenesis, diagnosis, treatment, and/or antimicrobial resistance. The synthesis of the results involved a narrative synthesis of the findings from the included studies. Results. A total of 25 articles met the inclusion criteria and provided valuable insights into Stenotrophomonas spp. infections. The distribution of reported cases by country, sample type, and antimicrobial resistance patterns was summarized. The prevalence of resistance to various antibiotics was also assessed, highlighting the need for continuous surveillance. Conclusion. This analysis revealed the presence of antimicrobial resistance in Stenotrophomonas spp., particularly in S. maltophilia. The high prevalence of antibiotic resistance underscores the importance of ongoing surveillance and control measures to combat antibiotic resistance. The diverse distribution of S. maltophilia across different sample types emphasizes the need for accurate diagnosis and identification. Addressing antimicrobial resistance in Stenotrophomonas spp. is essential for global public health.

Metrics

Metrics Loading ...

References

Brooke JS. Stenotrophomonas maltophilia is an emerging opportunistic pathogen globally. Clinical Microbiology Reviews. 2012;25(1): 2–41. https://doi.org/10.1128/CMR.00019-11.

Ghosh R, Chatterjee S, Mandal NC. Stenotrophomonas. In: Beneficial Microbes in Agro-Ecology. Elsevier; 2020. p. 427–442. https://doi.org/10.1016/B978-0-12-823414-3.00020-4. [Accessed May 6 2023].

Hugh R, Ryschenkow E. Pseudomonas maltophilia, an Alcaligenes-like Species. Journal of General Microbiology. 1961;26(1): 123–132. https://doi.org/10.1099/00221287-26-1-123.

Palleroni NJ, Bradbury JF. Stenotrophomonas, a New Bacterial Genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. International Journal of Systematic Bacteriology. 1993;43(3): 606–609. https://doi.org/10.1099/00207713-43-3-606.

Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ. Stenotrophomonas maltophilia : emerging disease patterns and challenges for treatment. Expert Review of Anti-infective Therapy. 2011;9(4): 471–488. https://doi.org/10.1586/eri.11.24.

Abbott I, Peleg A. Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies. Seminars in Respiratory and Critical Care Medicine. 2015;36(01): 099–110. https://doi.org/10.1055/s-0034-1396929.

Swings J, De Vos P, Van Den Mooter M, De Ley J. Transfer of Pseudomonas maltophilia Hugh 1981 to the Genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. International Journal of Systematic Bacteriology. 1983;33(2): 409–413. https://doi.org/10.1099/00207713-33-2-409.

Ouattara AS, Le Mer J, Joseph M, Macarie H. Transfer of Pseudomonas pictorum Gray and Thornton 1928 to genus Stenotrophomonas as Stenotrophomonas pictorum comb. nov., and emended description of the genus Stenotrophomonas. International Journal of Systematic and Evolutionary Microbiology. 2017;67(6): 1894–1900. https://doi.org/10.1099/ijsem.0.001880.

Notification that New Names and New Combinations Have Appeared in Volume 43, No. 3, of the IJSB. International Journal of Systematic Bacteriology. 1993;43(4): 866–866. https://doi.org/10.1099/00207713-43-4-866.

Whitman WB, [ed.]. Bergey's Manual of Systematics of Archaea and Bacteria.. 1st ed. Wiley; 2015. https://doi.org/10.1002/9781118960608. [Accessed May 6 2023].

Van Zyl E, Steyn PL. Differentiation of Phytopathogenic Pseudomonas and Xanthomonas Species and Pathovars by Numerical Taxonomy and Protein Gel Electrophoregrams. Systematic and Applied Microbiology. 1990;13(1): 60–71. https://doi.org/10.1016/S0723-2020(11)80181-5.

Mahdi O, Eklund B, Fisher N. Laboratory Culture and Maintenance of Stenotrophomonas maltophilia. Current Protocols in Microbiology. 2014;32(1). https://doi.org/10.1002/9780471729259.mc06f01s32.

Duan Z, Qin J, Li C, Ying C. Clinical and Molecular Epidemiology of Stenotrophomonas maltophilia in Pediatric Patients From a Chinese Teaching Hospital. Frontiers in cellular and infection microbiology. 2020;10: 411. https://doi.org/10.3389/fcimb.2020.00411.

Tan R, Liu J, Li M, Huang J, Sun J, Qu H. Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2014;47(2): 87–94. https://doi.org/10.1016/j.jmii.2012.11.006.

Palleroni NJ, Kunisawa R, Contopoulou R, Doudoroff M. Nucleic Acid Homologies in the Genus Pseudomonas. International Journal of Systematic Bacteriology. 1973;23(4): 333–339. https://doi.org/10.1099/00207713-23-4-333.

Van Den Mooter M, Swings J. Numerical Analysis of 295 Phenotypic Features of 266 Xanthomonas Strains and Related Strains and an Improved Taxonomy of the Genus. International Journal of Systematic Bacteriology. 1990;40(4): 348–369. https://doi.org/10.1099/00207713-40-4-348.

Brooke JS. Advances in the Microbiology of Stenotrophomonas maltophilia. Clinical Microbiology Reviews. 2021;34(3): e00030-19. https://doi.org/10.1128/CMR.00030-19.

Juhász E, Krizsán G, Lengyel G, Grósz G, Pongrácz J, Kristóf K. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary. Annals of clinical microbiology and antimicrobials. 2014;13: 333. https://doi.org/10.1186/s12941-014-0058-9.

Adegoke AA, Stenström TA, Okoh AI. Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy. Frontiers in Microbiology. 2017;8: 2276.

https://doi.org/10.3389/fmicb.2017.02276.

Sánchez MB. Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Frontiers in Microbiology. 2015;6. https://doi.org/10.3389/fmicb.2015.00658.

Said M, Tirthani E, Lesho E. Stenotrophomonas Maltophilia.. 2023rd ed. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK572123/

Sannathimmappa MB, Nambiar V, Aravindakshan R, Al-Kasaby NM. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman. Sultan Qaboos University medical journal. 2021;21(1): e66–e71. https://doi.org/10.18295/squmj.2021.21.01.009.

AbuTaha SA, Al-Kharraz T, Belkebir S, Abu Taha A, Zyoud SH. Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine. Scientific reports. 2022;12(1): 18003. https://doi.org/10.1038/s41598-022-21979-7.

Behnia M, Logan SC, Fallen L, Catalano P. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC research notes. 2014;7: 232. https://doi.org/10.1186/1756-0500-7-232.

Bousquet A, Malfuson JV, Sanmartin N, Konopacki J, MacNab C, Souleau B, et al. An 8-year survey of strains identified in blood cultures in a clinical haematology unit. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20(1): O7-12. https://doi.org/10.1111/1469-0691.12294.

Chong WH, Saha BK, Ramani A, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49(4): 591–605. https://doi.org/10.1007/s15010-021-01602-z.

Dat VQ, Vu HN, Nguyen The H, Nguyen HT, Hoang LB, Vu Tien Viet D, et al. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC infectious diseases. 2017;17(1): 493. https://doi.org/10.1186/s12879-017-2582-7.

Duan Z, Qin J, Liu Y, Li C, Ying C. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital. BMC microbiology. 2020;20(1): 294. https://doi.org/10.1186/s12866-020-01985-3.

Goldenberg SD, Dodgson AR, Barlow G, Parcell BJ, Jones L, Albur M, et al. Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK). Advances in therapy. 2022;39(8): 3602–3615. https://doi.org/10.1007/s12325-022-02177-3.

Hotta G, Matsumura Y, Kato K, Nakano S, Yunoki T, Yamamoto M, et al. Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PloS one. 2014;9(11): e112208. https://doi.org/10.1371/journal.pone.0112208.

Hu LF, Chen GS, Kong QX, Gao LP, Chen X, Ye Y, et al. Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China. PloS one. 2016;11(6): e0157693. https://doi.org/10.1371/journal.pone.0157693.

Huang YC, Wu PF, Lin YT, Wang FD. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2019;52(2): 304–311. https://doi.org/10.1016/j.jmii.2018.06.007.

Ince N, Yekenkurul D, Danış A, Çalışkan E, Akkaş İ. An evaluation of six-year Stenotrophomonas maltophilia infections in a university hospital. African health sciences. 2020;20(3): 1118–1123. https://doi.org/10.4314/ahs.v20i3.13.

Jia W, Wang J, Xu H, Li G. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. International journal of environmental research and public health. 2015;12(5): 5177–5195. https://doi.org/10.3390/ijerph120505177.

Jiang AM, Shi X, Liu N, Gao H, Ren MD, Zheng XQ, et al. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China. BMC infectious diseases. 2020;20(1): 452. https://doi.org/10.1186/s12879-020-05181-6.

Kim EJ, Kim YC, Ahn JY, Jeong SJ, Ku NS, Choi JY, et al. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains. BMC infectious diseases. 2019;19(1): 754. https://doi.org/10.1186/s12879-019-4394-4.

Kuo SH, Lin WR, Lin JY, Huang CH, Jao YT, Yang PW, et al. The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2018;51(3): 401–410. https://doi.org/10.1016/j.jmii.2017.08.016.

Mendes ET, Paez JIG, Ferraz JR, Marchi AP, Silva ILAFE, Batista MV, et al. Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole/ trimethoprim a problem? Revista do Instituto de Medicina Tropical de Sao Paulo. 2020;62: e96. https://doi.org/10.1590/S1678-9946202062096.

Mojica MF, Papp-Wallace KM, Taracila MA, Barnes MD, Rutter JD, Jacobs MR, et al. Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam. Antimicrobial agents and chemotherapy. 2017;61(10). https://doi.org/10.1128/AAC.00777-17.

Mojica MF, Rutter JD, Taracila M, Abriata LA, Fouts DE, Papp-Wallace KM, et al. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States. mBio. 2019;10(4). https://doi.org/10.1128/mBio.00405-19.

Motamedifar M, Heidari H, Yasemi M, Sedigh Ebrahim-Saraie H. Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units. Annali di igiene : medicina preventiva e di comunita. 2017;29(4): 264–272. https://doi.org/10.7416/ai.2017.2154.

Scheich S, Koenig R, Wilke AC, Lindner S, Reinheimer C, Wichelhaus TA, et al. Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival. PloS one. 2018;13(7): e0201169. https://doi.org/10.1371/journal.pone.0201169.

Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, et al. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2016;49(3): 378–386. https://doi.org/10.1016/j.jmii.2014.06.005.

Carmody LA, Spilker T, LiPuma JJ. Reassessment of Stenotrophomonas maltophilia Phenotype. Journal of Clinical Microbiology. 2011;49(3): 1101–1103. https://doi.org/10.1128/JCM.02204-10.

Burdge DR, Noble MA, Campbell ME, Krell VL, Speert DP. Xanthomonas maltophilia Misidentified as Pseudomonas cepacia in Cultures of Sputum from Patients with Cystic Fibrosis: A Diagnostic Pitfall with Major Clinical Implications. Clinical Infectious Diseases. 1995;20(2): 445–448. https://doi.org/10.1093/clinids/20.2.445.

Denton M, Kerr KG. Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia. Clinical Microbiology Reviews. 1998;11(1): 57–80. https://doi.org/10.1128/CMR.11.1.57.

Kataoka D, Fujiwara H, Kawakami T, Tanaka Y, Tanimoto A, Ikawa S, et al. The indirect pathogenicity of Stenotrophomonas maltophilia. International Journal of Antimicrobial Agents. 2003;22(6): 601–606. https://doi.org/10.1016/S0924-8579(03)00244-9.

Denton M, Hall MJ, Todd NJ, Kerr KG, Littlewood JM. Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium. Clinical Microbiology and Infection. 2000;6(7): 395–396. https://doi.org/10.1046/j.1469-0691.2000.00098.x.

Hafiz TA, Aldawood E, Albloshi A, Alghamdi SS, Mubaraki MA, Alyami AS, et al. Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: Understanding of the Recent Three Years' Trends. Microorganisms. 2022;10(12): 2506. https://doi.org/10.3390/microorganisms10122506.